These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7504138)

  • 21. Red blood cell substitutes and artificial blood.
    Bowman RJ
    Hum Pathol; 1983 Mar; 14(3):218-20. PubMed ID: 6832769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of intracoronary infusion of arterial blood or Fluosol-DA 20% on regional myocardial metabolism and function during brief coronary artery occlusions.
    Tokioka H; Miyazaki A; Fung P; Rajagopalan RE; Kar S; Meerbaum S; Corday E; Drury JK
    Circulation; 1987 Feb; 75(2):473-81. PubMed ID: 2948736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maintenance of aerobic metabolism during global ischemia with perfluorocarbon cardioplegia improves myocardial preservation.
    Flaherty JT; Jaffin JH; Magovern GJ; Kanter KR; Gardner TJ; Miceli MV; Jacobus WE
    Circulation; 1984 Mar; 69(3):585-92. PubMed ID: 6692519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal myocardial protection with fluosol cardioplegia.
    Magovern GJ; Flaherty JT; Gott VL; Bulkley BH; Gardner TJ
    Ann Thorac Surg; 1982 Sep; 34(3):249-57. PubMed ID: 6810773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged support of working rabbit hearts using Fluosol-43 or erythrocyte media.
    Segel LD; Ensunsa JL; Boyle WA
    Am J Physiol; 1987 Feb; 252(2 Pt 2):H349-59. PubMed ID: 3812749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol.
    Kent KM; Cleman MW; Cowley MJ; Forman MB; Jaffe CC; Kaplan M; King SB; Krucoff MW; Lassar T; McAuley B
    Am J Cardiol; 1990 Aug; 66(3):279-84. PubMed ID: 2195864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perfluorocarbons as blood substitutes.
    Waxman K
    Ann Emerg Med; 1986 Dec; 15(12):1423-4. PubMed ID: 3777615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-thaw recovery of cryopreserved cells. Enhanced viability by oxygenated perfluorocarbon or Pluronic F-68.
    Anthony P; Lowe KC; Davey MR; Power JB
    Adv Exp Med Biol; 1997; 428():483-8. PubMed ID: 9500088
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of a perfluorochemical emulsion on the rat hepatic mixed function oxidase system.
    Ravis WR; Ramakanth S; Brzozowski DM; Hamrick ME
    J Pharm Pharmacol; 1992 Mar; 44(3):219-23. PubMed ID: 1354727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superiority of perfluorocarbon cardioplegia over blood or crystalloid cardioplegia.
    Kanter KR; Jaffin JH; Ehrlichman RJ; Flaherty JT; Gott VL; Gardner TJ
    Circulation; 1981 Aug; 64(2 Pt 2):II75-80. PubMed ID: 7249332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of perfluorotributylamine/pluronic F-68 stem-emulsion (FC43se) against reperfusion injury in ischemic rabbit lungs.
    Ueno T; Matsuura Y; Wada S; Murakami H; Kajihara H
    Transplant Proc; 1997; 29(1-2):1349-53. PubMed ID: 9123336
    [No Abstract]   [Full Text] [Related]  

  • 32. Enhanced post-thaw viability of cryopreserved cells by oxygenated perfluorocarbon or Pluronic F-68.
    Anthony P; Lowe KC; Davey MR; Power JB
    Artif Cells Blood Substit Immobil Biotechnol; 1998 Jan; 26(1):27-33. PubMed ID: 9507754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of the extent of ischemic skeletal muscle necrosis by perfusion with oxygenated perfluorocarbon.
    Mohan C; Gennaro M; Marini C; Ascer E
    Am J Surg; 1992 Sep; 164(3):194-8. PubMed ID: 1329572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies of controlled reperfusion after ischemia. XIX. Reperfusate composition: benefits of blood cardioplegia over fluosol DA cardioplegia during regional reperfusion--importance of including blood components in the initial reperfusate.
    Acar C; Partington MT; Buckberg GD
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):284-93. PubMed ID: 1992239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cardiovascular effects of the surfactant pluronic F68 in anesthetized dogs.
    Gosselin AM; Biro GP
    Adv Exp Med Biol; 1990; 277():291-9. PubMed ID: 2096635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of Fluosol-DA infusion on the complement activation and on the blood level of histamine in man.
    Fukushima K; Nakamura M; Hinuma K
    Prog Clin Biol Res; 1983; 122():291-8. PubMed ID: 6878373
    [No Abstract]   [Full Text] [Related]  

  • 37. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
    Chaplin DJ; Horsman MR; Aoki DS
    Br J Cancer; 1991 Jan; 63(1):109-13. PubMed ID: 1846549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasonic enhancement of myocardial infarction with perfluorocarbon compounds in dogs.
    Mattrey RF; Andre MP
    Am J Cardiol; 1984 Jul; 54(1):206-10. PubMed ID: 6741815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation.
    Bajaj AK; Cobb MA; Virmani R; Gay JC; Light RT; Forman MB
    Circulation; 1989 Mar; 79(3):645-56. PubMed ID: 2537160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Blood plasma protein adsorption capacity of perfluorocarbon emulsion stabilized by proxanol 268 (in vitro and in vivo studies)].
    Sklifas AN; Zhalimov VK; Temnov AA; Kukushkin NI
    Biofizika; 2012; 57(2):317-24. PubMed ID: 22594289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.